Literature DB >> 17061603

Silent liver diseases in autopsies from forensic medicine of Tehran.

Rasoul Sotoudehmanesh1, Masoud Sotoudeh, Ali Ali-Asgari, Behnoush Abedi-Ardakani, Seyed-Mohammad Tavangar, Ali Khakinejad, Zohreh Sadeghi, Reza Malekzadeh.   

Abstract

BACKGROUND: Histology is the unique method for diagnosis of silent liver diseases; so, we aimed to determine the prevalence of fatty liver and other silent liver diseases among those who passed away for causes other than liver diseases in Tehran.
METHODS: Over a two-year period (2002 - 2004) we enrolled autopsies performed at the Forensic Medicine Center in Tehran. Demographic information, history of known acute and chronic liver diseases, and causes of death were determined. Samples from the right and left lobe and one sample from deeper areas of the liver as well as specimens from any grossly visible lesions were obtained in each case. Tissue sections stained by hematoxylin and eosin were evaluated. Reticulin and Masson's trichrome stains were also performed for evaluation of liver architecture and degree of fibrosis when necessary.
RESULTS: Satisfactory tissue samples for histologic evaluation were available in 896 cases (777 males) with a mean age of 43.8 years. Normal histology was found in 467 cases (52.1%). Important findings included: steatosis in 283 (31.6%), steatohepatitis in 19 (2.1%), chronic hepatitis in 23 (2.6%), and cirrhosis in 7 (0.8%) cases. Causes of death were: trauma (35%), acute myocardial infarction (30%), opiate overdose (13%), cerebrovascular accidents (4%), infectious diseases (3%), and others (15%).
CONCLUSION: Silent diseases of the liver are not uncommon. Steatosis is the most common finding but inflammatory disorders comprise a significant minority.

Entities:  

Mesh:

Year:  2006        PMID: 17061603

Source DB:  PubMed          Journal:  Arch Iran Med        ISSN: 1029-2977            Impact factor:   1.354


  6 in total

1.  Steatosis and steatohepatitis in postmortem material from Northwestern Greece.

Authors:  Christos-D Zois; Gerasimos-H Baltayiannis; Anna Bekiari; Anna Goussia; Peter Karayiannis; Michalis Doukas; Demetrios Demopoulos; Antigoni Mitsellou; Theodoros Vougiouklakis; Vasiliki Mitsi; Epameinondas-V Tsianos
Journal:  World J Gastroenterol       Date:  2010-08-21       Impact factor: 5.742

2.  Persistent alanine aminotransferase elevation among the general Iranian population: prevalence and causes.

Authors:  Raika Jamali; Mahmoodreza Khonsari; Shahin Merat; Masoud Khoshnia; Elham Jafari; Alireza Bahram Kalhori; Hassan Abolghasemi; Sedighe Amini; Mahtab Maghsoudlu; Mohammad-Reza Deyhim; Houri Rezvan; Akram Pourshams
Journal:  World J Gastroenterol       Date:  2008-05-14       Impact factor: 5.742

3.  How Much Weight Loss is Effective on Nonalcoholic Fatty Liver Disease?

Authors:  Alireza Ghaemi; Fourugh Azam Taleban; Azita Hekmatdoost; Alireza Rafiei; Vahid Hosseini; Zohreh Amiri; Reza Homayounfar; Hafez Fakheri
Journal:  Hepat Mon       Date:  2013-12-07       Impact factor: 0.660

4.  Prevalence of non-alcoholic fatty liver disease in patients with coronary artery disease.

Authors:  Babak Baharvand-Ahmadi; Khalil Sharifi; Mehrdad Namdari
Journal:  ARYA Atheroscler       Date:  2016-07

5.  Prevalence of Nonalcoholic Steatohepatitis in Iran: A Population based Study.

Authors:  Aa Sohrabpour; H Rezvan; S Amini-Kafiabad; Mr Dayhim; S Merat; A Pourshams
Journal:  Middle East J Dig Dis       Date:  2010-01

6.  The Prevalence of Metabolic Syndrome In Non-alcoholic Fatty Liver Disease; A Population-Based Study.

Authors:  Mohammad Reza Fattahi; Ramin Niknam; Alireza Safarpour; Masood Sepehrimanesh; Mehrzad Lotfi
Journal:  Middle East J Dig Dis       Date:  2016-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.